跳至主要内容
临床试验/NCT06923631
NCT06923631尚未招募不适用

Unravelling the Measles Paradox in Children: a Disease Associated With Both Immune Suppression and Immune Activation

Erasmus Medical Center1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2026年1月3日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
试验地点
1
主要终点
Compare measles-induced loss of pathogen-specific antibodies

研究概览

简要总结

Measles is caused by measles virus (MeV). The disease is associated with lymphopenia and immune suppression, which is an important cause of measles-associated morbidity and mortality. Measles-induced immune suppression can last several years, whereas measles lymphopenia is usually resolved within two weeks. At the same time, measles induces lifelong immunity. This apparent contradiction, known as the 'measles paradox', was partially solved when investigators demonstrated that MeV infects and depletes pre-existing memory cells, thereby causing 'immune amnesia'. This model is supported by observations in animal models and clinical studies, but several questions remain to be addressed, like the duration of measles-induced amnesia and changes in the immune repertoire after measles. to address the immunological questions regarding MeV infection.

详细描述

Measles is caused by measles virus (MeV). The disease is associated with lymphopenia and immune suppression, which is an important cause of measles-associated morbidity and mortality. Measles-induced immune suppression can last several years, whereas measles lymphopenia is usually resolved within two weeks. At the same time, measles induces lifelong immunity. This apparent contradiction, known as the 'measles paradox', was partially solved when investigators demonstrated that MeV infects and depletes pre-existing memory cells, thereby causing 'immune amnesia'. This model is supported by observations in animal models and clinical studies, but several questions remain to be addressed, like the duration of measles-induced amnesia and changes in the immune repertoire after measles. Recently, investigators have acquired permission to address these remaining questions in 18-25 years old adults (MEC-2024-0230). However, investigators have reservations about the feasibility of including enough participants between 18 and 25 years old that have not been vaccinated against or infected with MeV; it is possible that investigators will not reach sufficient inclusions to address the immunological questions regarding MeV infection in that protocol. Therefore, investigators propose to additionally study these questions in children in the age of 4 up to and including 17.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
4 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Aged 4 - 17 years old
  • Susceptible to measles
  • No pre-existing immunity against measles (vaccination or earlier infection)
  • Aged 4 - 17 years old
  • Protected against measles due to vaccination or earlier infection

排除标准

  • A potential subject who meets any of the following criteria will be excluded from participation in this study:
  • Diagnosed chronic disease that lasted over 3 months
  • Immune suppression (due to medication or underlying disease)
  • Group A; Detectable MeV-antibodies in the T1 blood sample

结局指标

主要结局

Compare measles-induced loss of pathogen-specific antibodies

时间窗: 36 months

The investigators will measure changes in the immune repertoire using longitudinal samples obtained from children who are infected with MeV. To this end, they will measure pathogen-specific antibody responses (titers) pre- and post-measles and compare these to determine whether measles led to a loss of pathogen-specific antibodies.

Compare measles-induced loss of pathogen-specific T-cells

时间窗: 36 months

The investigators will measure changes in the immune repertoire using longitudinal samples obtained from children who are infected with MeV. To this end, they will measure pathogen-specific T-cell responses (frequencies) pre- and post-measles and compare these to determine whether measles led to a loss of pathogen-specific T-cells.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Corine Geurts van Kessel

Medical microbiologist

Erasmus Medical Center

研究点 (1)

Loading locations...

相似试验